Company Overview of Celgene Cellular Therapeutics
Celgene Cellular Therapeutics engages in the research, recovery culture-expansion, preservation, development, and distribution of placental cells. The company develops placental cells, including stem and progenitor cells as therapeutic agents. It discovers and develops therapeutics from cells derived from the human placenta, as well as from the umbilical cord. The company develops stem cells for therapeutic applications in cancer, as well as autoimmune, cardiovascular, neurological, and degenerative diseases. It also operates a private umbilical cord blood bank. The company was formerly known as Anthrogenesis Corp. and changed its name to Celgene Cellular Therapeutics in 2002. Celgene Cellul...
7 Powder Horn Drive
Warren, NJ 07059-5190
Key Executives for Celgene Cellular Therapeutics
Chief Executive Officer, President and Director
Compensation as of Fiscal Year 2014.
Celgene Cellular Therapeutics Key Developments
Alliqua Amends Licensing Agreement with Celgene Cellular Therapeutics to Market Biovance
Oct 6 14
Alliqua announced that it has amended a licensing agreement with Celgene Cellular Therapeutics, giving Aliqua the right to market advanced wound care product Biovance for podiatric and orthopedic applications. Biovance is a drug used to manage non-infected wounds including chronic and acute diabetic, pressure, venous and chronic vascular ulcers, and surgical and trauma woulds such as abrasions, lacerations and second-degree burns. Podiatrists use Biovance for sports medicine purposes.
Celgene Cellular Therapeutics Presents at Stem Cell Meeting on the Mesa Partnering Forum, Oct-08-2014 07:30 AM
Oct 4 14
Celgene Cellular Therapeutics Presents at Stem Cell Meeting on the Mesa Partnering Forum, Oct-08-2014 07:30 AM. Venue: Estancia La Jolla Hotel & Spa, 9700 North Torrey Pines Road, La Jolla, CA 92037, United States. Speakers: Stewart Abbot, Ph.D., Executive Director, Integrative Research.
Celgene Cellular Therapeutics Presents at Alliance for Regenerative Medicine 2nd Annual Regen Med Investor Day, Mar-26-2014
Feb 27 14
Celgene Cellular Therapeutics Presents at Alliance for Regenerative Medicine 2nd Annual Regen Med Investor Day, Mar-26-2014. Venue: Metropolitan Club, One East 60th Street, New York, NY 10022, United States. Presentation Date & Speakers: Mar-26-2014, Gregory Russotti, Vice President, Technical Operations, Perry Karsen, CEO.
Similar Private Companies By Industry
Recent Private Companies Transactions